![Akihiko Shimauchi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Akihiko Shimauchi
Director/Board Member at CHORDIA THERAPEUTICS INC.
Akihiko Shimauchi active positions
Companies | Position | Start | End |
---|---|---|---|
CHORDIA THERAPEUTICS INC. | Independent Dir/Board Member | 2022-09-30 | - |
Director/Board Member | 2022-09-30 | - | |
Comptroller/Controller/Auditor | 2017-12-31 | 2022-09-30 | |
INDEE Medical, Inc.
![]() INDEE Medical, Inc. Medical SpecialtiesHealth Technology INDEE Medical, Inc. engages in the manufacture and sale of medical related products. It distributes ReCell, a treatment kit that creates cell suspension once sprayed or applied on wounds with damage. It is also being used for scars, vitiligo, nevus, leg ulcers, and in cosmetic surgery. The company was founded in January 2016 and is headquartered in Tokyo, Japan. | Director/Board Member | - | - |
Chief Executive Officer | - | - | |
Founder | - | - | |
President | - | - |
Career history of Akihiko Shimauchi
Former positions of Akihiko Shimauchi
Companies | Position | Start | End |
---|---|---|---|
Ortho-Clinical Diagnostics KK | Director/Board Member | - | - |
Sales & Marketing | - | - | |
Fujirebio, Inc.
![]() Fujirebio, Inc. Medical SpecialtiesHealth Technology Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan. | President | - | - |
American Hospital Supply Corp. | Corporate Officer/Principal | - | - |
AJINOMOTO CO., INC. | Corporate Officer/Principal | - | - |
Quintiles Transnational Japan K.K.
![]() Quintiles Transnational Japan K.K. Pharmaceuticals: MajorHealth Technology Part of Quintiles Transnational Corp., Quintiles Transnational Japan K.K. is a Japanese company that manufactures and distributes pharmaceutical drugs and provides training services for medical professionals. The company is based in Tokyo, Japan. Yoh Narimatsu has been the CEO of the company since 2006. | Corporate Officer/Principal | - | - |
M's Science Corp.
![]() M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | President | 2009-03-30 | - |
Training of Akihiko Shimauchi
Waseda University | Undergraduate Degree |
Statistics
International
Japan | 9 |
United States | 2 |
Operational
President | 3 |
Corporate Officer/Principal | 3 |
Director/Board Member | 3 |
Sectoral
Health Technology | 6 |
Commercial Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
AJINOMOTO CO., INC. | Consumer Non-Durables |
CHORDIA THERAPEUTICS INC. | Health Technology |
Private companies | 6 |
---|---|
M's Science Corp.
![]() M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Commercial Services |
Quintiles Transnational Japan K.K.
![]() Quintiles Transnational Japan K.K. Pharmaceuticals: MajorHealth Technology Part of Quintiles Transnational Corp., Quintiles Transnational Japan K.K. is a Japanese company that manufactures and distributes pharmaceutical drugs and provides training services for medical professionals. The company is based in Tokyo, Japan. Yoh Narimatsu has been the CEO of the company since 2006. | Health Technology |
American Hospital Supply Corp. | Health Technology |
Fujirebio, Inc.
![]() Fujirebio, Inc. Medical SpecialtiesHealth Technology Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan. | Health Technology |
Ortho-Clinical Diagnostics KK | |
INDEE Medical, Inc.
![]() INDEE Medical, Inc. Medical SpecialtiesHealth Technology INDEE Medical, Inc. engages in the manufacture and sale of medical related products. It distributes ReCell, a treatment kit that creates cell suspension once sprayed or applied on wounds with damage. It is also being used for scars, vitiligo, nevus, leg ulcers, and in cosmetic surgery. The company was founded in January 2016 and is headquartered in Tokyo, Japan. | Health Technology |
- Stock Market
- Insiders
- Akihiko Shimauchi
- Experience